Clinical Trial Update: Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021 [Phase 4]

View source ↗

Summary

Phase 4 trial update on efficacy and safety of a recombinant human insulin patch.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Recombinant human insulin patch (insulin patch)

Snippet

Sponsor: Zhejiang Provincial People's Hospital | Conditions: type1diabetes, Type2 Diabetes | Phase 4 | Status: UNKNOWN